Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1964 1
1968 1
1970 1
1972 2
1973 1
1974 2
1975 4
1976 2
1977 1
1982 2
1983 3
1984 2
1985 3
1986 8
1988 2
1989 11
1990 15
1991 8
1992 10
1993 6
1994 8
1995 29
1996 4
1997 4
1998 4
1999 3
2000 2
2001 2
2002 2
2003 4
2004 7
2005 8
2006 5
2007 3
2008 4
2009 1
2010 1
2012 3
2017 6
2018 5
2019 3
2020 9
2021 8
2022 7
2023 8
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

226 results

Results by year

Filters applied: . Clear all
Page 1
Safety of Nirsevimab for RSV in Infants with Heart or Lung Disease or Prematurity.
Domachowske J, Madhi SA, Simões EAF, Atanasova V, Cabañas F, Furuno K, Garcia-Garcia ML, Grantina I, Nguyen KA, Brooks D, Chang Y, Leach A, Takas T, Yuan Y, Griffin MP, Mankad VS, Villafana T; MEDLEY Study Group. Domachowske J, et al. Among authors: furuno k. N Engl J Med. 2022 Mar 3;386(9):892-894. doi: 10.1056/NEJMc2112186. N Engl J Med. 2022. PMID: 35235733 Clinical Trial. No abstract available.
Safety of Re-dosing Nirsevimab Prior to RSV Season 2 in Children With Heart or Lung Disease.
Domachowske JB, Chang Y, Atanasova V, Cabañas F, Furuno K, Nguyen KA, Banu I, Kubiak RJ, Leach A, Mankad VS, Shroff M, Takas T, Villafana T, Wählby Hamrén U. Domachowske JB, et al. Among authors: furuno k. J Pediatric Infect Dis Soc. 2023 Aug 31;12(8):477-480. doi: 10.1093/jpids/piad052. J Pediatric Infect Dis Soc. 2023. PMID: 37466917 Free PMC article.
Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial.
Kobayashi T, Saji T, Otani T, Takeuchi K, Nakamura T, Arakawa H, Kato T, Hara T, Hamaoka K, Ogawa S, Miura M, Nomura Y, Fuse S, Ichida F, Seki M, Fukazawa R, Ogawa C, Furuno K, Tokunaga H, Takatsuki S, Hara S, Morikawa A; RAISE study group investigators. Kobayashi T, et al. Among authors: furuno k. Lancet. 2012 Apr 28;379(9826):1613-20. doi: 10.1016/S0140-6736(11)61930-2. Epub 2012 Mar 8. Lancet. 2012. PMID: 22405251 Clinical Trial.
Clinical significance of serum cytokine profiles for differentiating between Kawasaki disease and its mimickers.
Kaneko S, Shimizu M, Shimbo A, Irabu H, Yokoyama K, Furuno K, Tanaka T, Ueno K, Fujita S, Iwata N, Fujimura J, Akamine K, Mizuta M, Nakagishi Y, Minato T, Watanabe K, Kobayashi A, Endo T, Tabata K, Mori M, Morio T. Kaneko S, et al. Among authors: furuno k. Cytokine. 2023 Sep;169:156280. doi: 10.1016/j.cyto.2023.156280. Epub 2023 Jun 23. Cytokine. 2023. PMID: 37356260
Clinical Characteristics of Cryopyrin-Associated Periodic Syndrome and Long-Term Real-World Efficacy and Tolerability of Canakinumab in Japan: Results of a Nationwide Survey.
Miyamoto T, Izawa K, Masui S, Yamazaki A, Yamasaki Y, Matsubayashi T, Shiraki M, Ohnishi H, Yasumura J, Kawabe T, Miyamae T, Matsubara T, Arakawa N, Ishige T, Takizawa T, Shimbo A, Shimizu M, Kimura N, Maeda Y, Maruyama Y, Shigemura T, Furuta J, Sato S, Tanaka H, Izumikawa M, Yamamura M, Hasegawa T, Kaneko H, Nakagishi Y, Nakano N, Iida Y, Nakamura T, Wakiguchi H, Hoshina T, Kawai T, Murakami K, Akizuki S, Morinobu A, Ohmura K, Eguchi K, Sonoda M, Ishimura M, Furuno K, Kashiwado M, Mori M, Kawahata K, Hayama K, Shimoyama K, Sasaki N, Ito T, Umebayashi H, Omori T, Nakamichi S, Dohmoto T, Hasegawa Y, Kawashima H, Watanabe S, Taguchi Y, Nakaseko H, Iwata N, Kohno H, Ando T, Ito Y, Kataoka Y, Saeki T, Kaneko U, Murase A, Hattori S, Nozawa T, Nishimura K, Nakano R, Watanabe M, Yashiro M, Nakamura T, Komai T, Kato K, Honda Y, Hiejima E, Yonezawa A, Bessho K, Okada S, Ohara O, Takita J, Yasumi T, Nishikomori R; Japan CAPS Working Group. Miyamoto T, et al. Among authors: furuno k. Arthritis Rheumatol. 2024 Jun;76(6):949-962. doi: 10.1002/art.42808. Epub 2024 Mar 7. Arthritis Rheumatol. 2024. PMID: 38268504
Lumicitabine, an orally administered nucleoside analog, in infants hospitalized with respiratory syncytial virus (RSV) infection: Safety, efficacy, and pharmacokinetic results.
Oey A, McClure M, Symons JA, Chanda S, Fry J, Smith PF, Luciani K, Fayon M, Chokephaibulkit K, Uppala R, Bernatoniene J, Furuno K, Stanley T, Huntjens D, Witek J; 503 and RSV2004 Study Groups. Oey A, et al. Among authors: furuno k. PLoS One. 2023 Jul 19;18(7):e0288271. doi: 10.1371/journal.pone.0288271. eCollection 2023. PLoS One. 2023. PMID: 37467213 Free PMC article. Clinical Trial.
[Primidone].
Furuno K, Kawasaki H, Gomita Y. Furuno K, et al. Nihon Rinsho. 1995 Feb;53 Su Pt 1:928-30. Nihon Rinsho. 1995. PMID: 8753590 Review. Japanese. No abstract available.
[Phenobarbital].
Kawasaki H, Furuno K, Gomita Y. Kawasaki H, et al. Among authors: furuno k. Nihon Rinsho. 1995 Feb;53 Su Pt 1:921-3. Nihon Rinsho. 1995. PMID: 8753588 Review. Japanese. No abstract available.
[Phenytoin].
Furuno K, Kawasaki H, Gomita Y. Furuno K, et al. Nihon Rinsho. 1995 Feb;53 Su Pt 1:924-7. Nihon Rinsho. 1995. PMID: 8753589 Review. Japanese. No abstract available.
226 results